Results 91 to 100 of about 3,931 (193)

Have no fear, IR is here: A case of right brachiocephalic vein /svc recanalization for port placement

Radiology Case Reports
A patient with a history of cystic fibrosis and bilateral lung transplant presented internal jugular port placement for extracorporeal photopheresis in the setting of acute rejection.
Garrett DePalma, DO, Tomas Mujo, DO
doaj   +1 more source

Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD

Patient Preference and Adherence, 2015
Hongming Zhang, Runzhe Chen, Jian Cheng, Nan Jin, Baoan Chen Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People’s Republic of China ...
Zhang H, Chen R, Cheng J, Jin N, Chen B
doaj  

Current Research of Extracorporeal Photopheresis and Future Applications [PDF]

, 2014
Photopheresis, also known as Extracorporeal Photopheresis (ECP) is making inroads in treatment of previously untreatable diseases. As the medical world has delved deeper into, Although the mechanisms of photopheresis are largely unknown, increasingly ...
Lederer, Chaim
core   +1 more source

Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease [PDF]

Chronic graft-versus-host disease; Extracorporeal photopheresis; Steroid-refractory diseaseEnfermedad crónica de injerto contra huésped; Fotoféresis extracorpórea; Enfermedad refractaria a esteroidesMalaltia crònica d'empelt contra hoste; Fotofèresi ...
DeFilipp, Zachariah, Fox, Maria Laura, Holderried, Tobias, Mehra, Varun, Michonneau, David, Pashley, Alex   +5 more
core   +1 more source

Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cells [PDF]

, 2010
One of the ultimate goals in transplantation is to develop novel therapeutic methods for induction of donor-specific tolerance to reduce the side effects caused by the generalized immunosuppression associated to the currently used pharmacologic regimens.
A Ariel, A Krispin, A Lamioni, A Lamioni, A Maeda, A Maeda, A Ross, Adrian E. Morelli, Adriana T. Larregina, AE Morelli, AE Morelli, AE Morelli, AJ Adler, AT Larregina, B Sauter, BC Oh, BC Speich, BC Urban, C Kurts, C Scheinecker, C-Q Xia, CA Williams, CG Persijn, CH Qiu, D Hawiger, DC Brennan, DL Xu, E Gatza, E Sun, EM Behrens, EM Behrens, F Kleinclauss, F Meloni, F Wermeling, F-P Huang, G Castellano, G Opelz, G Ren, HT Greinix, HW Lim, I Baumann, I Di Biaso, I Verbovetski, J Dalgaard, J Ludvigsson, JC Madsen, JF George, JH Horina, JMJ Bhandari, K Inaba, K Kishimoto, K Liu, K Morimoto, K Nagata, K Stadler, KR Suchin, KS Ravichandran, L Bonifaz, L Truedsson, L Urbani, L-P Erwig, LI Craciun, LM Stuart, M Albert, M Botto, M Carvalho Bittencourt De, M Cvetanovic, M Di Renzo, M Gerner, M Gray, M Hivelin, M Niimi, M Nouri-Shirazi, M Perez, M Skoberne, M Takahashi, M-LN Huynh, MA Stark, MA Wallet, MB Parr, MC Bickerstaff, ME Flowers, ML Albert, ML Albert, ML Barr, ML Wood, MR Costanzo-Nordin, MR Costanzo-Nordin, MR Ehrenstein, N Luckashenak, O Salvatierra, P Gurung, P Pepino, P Saas, P Sen, PL Cohen, PR Taylor, R Hanayama, R Kushwah, R Rizzo, RE Voll, RM Steinman, RM Steinman, RM Steinman, RS Scott, S Gallucci, S Kim, S Nagata, S Perruche, S Perruche, S Schmitt, SA Quezada, SJ Divito, T Iyoda, T Nakano, TA Ferguson, U Holtick, U Johansson, V Rao, VA Fadok, VA Patel, W Chen, WK Ip, WT Newton, X Chen, Y Gao, Y Mishima, Y Miyake, Y Shoshan, Z Chen, Z Wang, Z Wang   +131 more
core   +2 more sources

Vascular access considerations for extracorporeal photopheresis [PDF]

Transfusion, 2018
Extracorporeal photopheresis is an immunomodulatory therapy indicated for patients with cutaneous T‐cell lymphoma, graft‐versus‐host disease, and heart or lung allograft rejection. Whole blood from the patient is drawn into the photopheresis instrument where it is separated into its components.
openaire   +2 more sources

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

Experimental Hematology & Oncology, 2012
We report the successful treatment and sustained molecular remission using single agent nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. Compared
Farnsworth Paul, Ward David, Reddy Vijay
doaj   +1 more source

Efficacy of Narrowband UVB vs. PUVA in Patients with Early-Stage Mycosis Fungoides [PDF]

, 2010
INTRODUCTION: Mycosis fungoides (MF) is a non-Hodgkin's T-cell lymphoma of the skin that often begins as limited patches and plaques with slow progression to systemic involvement.
Apetato, M, Ponte, P, Serrão, V
core   +1 more source

Risk factors for recurrent C lostridium difficile infection in hematopoietic stem cell transplant recipients [PDF]

, 2014
Background Recurrent C lostridium difficile infection ( CDI ) represents a significant burden on the healthcare system and is associated with poor outcomes in hematopoietic stem cell transplant ( HSCT ) patients.
Aronoff, D.M., Frame, D., Huang, A.M., Marini, B.L., Nagel, J.L.   +4 more
core   +1 more source

Extracorporeal photopheresis for graft-versus-host disease: The role of patient, transplant, and classification criteria and hematologic values on outcome - Results from a large single-center study [PDF]

, 2014
BACKGROUND: Extracorporeal photopheresis (ECP) has been shown as active therapy for graft-versus-host disease (GVHD). STUDY DESIGN AND METHODS: The aim was to ascertain the role of ECP in 71 patients with steroid-refractory or -dependent acute and ...
Albiani, Roberto, Berger, Massimo, Fagioli, Franca, Sini, Bruno   +3 more
core   +2 more sources